Proactive Investors article18 Mar 2019 20:27
Positive write up today in Proactiveinvestors . co .uk
Probably wont be able to link so here are a few extracts
“This market is going to explode and we are very well placed”
=====================================================
Having already agreed a deal with Thermo Fisher, another gene sequencing giant, in 2014, the settlement gave Yourgene a foothold on the platforms that account for 90% of sample testing globally.
That presence should not be underestimated, says Rees.
“We go to customers and say we are on either.”
That relationship with Illumina is now fantastic, he adds, and more importantly, rather than being in court, Yourgene’s management can focus on growing the company.
==================================================
The number of IONA tests carried out in the six months to September, jumped by 73% to 38,000, while revenues rose 45% to £3.9mln.
But that is only scratching the surface, believes Rees.
=================================================
Numbers of tests rising in emerging markets
And adoption of NIPT is growing rapidly.
In the Netherlands for example, all pregnancies are now screened.
Here in the UK, moves are underway to screen all high-risk births and eventually it seems likely the NHS will adopt a similar policy.
At a cost of between £300-600 for an NIPT, the private sector is also an option.
=========================================================
In December, Rees said he expects this current half year to be its strongest half to date and Yourgene will enter the new financial year effectively debt-free, with no distractions from litigation.
“This market is going to explode and we are very well placed.”
Sign In
Follow the stocks
